CNS pipeline · person
Antony Loebel, MD
Chief Medical Officer and President of Clinical Development at Seaport Therapeutics. Board-certified psychiatrist and former President and CEO of Sunovion Pharmaceuticals (2019–2023), where he was instrumental in the development and commercialization of LATUDA (lurasidone) for schizophrenia and bipolar depression.
- 1 company
Courtesy Seaport Therapeutics
Current roles
- Seaport Therapeutics, Inc.Chief Medical Officer and President of Clinical Development · Executive
Appears with
People sharing a company with Antony.
- Bob Hombach · Seaport Therapeutics, Inc.
- Daphne Zohar · Seaport Therapeutics, Inc.
- David Wheadon · Seaport Therapeutics, Inc.
- Denice Torres · Seaport Therapeutics, Inc.
- Eric Green · Seaport Therapeutics, Inc.
- Jason Pitts · Seaport Therapeutics, Inc.
- Jim Healy · Seaport Therapeutics, Inc.
- Lana Gladstein · Seaport Therapeutics, Inc.
- Lauren White · Seaport Therapeutics, Inc.
- Michael Chen · Seaport Therapeutics, Inc.
- Sandi Peterson · Seaport Therapeutics, Inc.
- Sharon Mates · Seaport Therapeutics, Inc.
- Steven Paul · Seaport Therapeutics, Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.